Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 157 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1561 6.8 months Advanced NSCLC 4 Chemotherapy
Jining First People’s Hospital China 5/2015
Treatment Details: Patients: This phase 2 study involved 56 advanced non-small-cell lung cancer patients who had received prior platinum-based chemotherapy. The median patient age was 59.6 years and 55.4% we
 
1562 6.8 months Advanced urothelial carcinoma 4 Biologic therapy
Cleveland Clinic United States 9/2009
Treatment Details: Patients: This phase 2 study involved 22 advanced urothelial carcinoma patients who had received one prior chemotherapy regimen. The median patient age was 66 years and 14 were male. Tr
 
1563 6.8 months Metastatic or advanced breast cancer 5 Biologic therapy
Dana Farber Cancer Institute United States 6/2008
Treatment Details: Patients: This phase II study involved 229 women with refractory advanced or metastatic breast cancer. The majority (95%) had stage IV disease. The median age was 53, ranging from 32 to 7
 
1564 6.8 months Advanced mesothelioma 5 Chemotherapy
Washington University School of Medicine United States 3/2005
Treatment Details: Patients: This Phase II study involved 43 patients with advanced mesothelioma. Thirty-nine patients were men and four were women. The median age was 72 years. Treatment: The treatment c
 
1565 6.8 months Recurrent GBM 4 Chemotherapy
Institut Gustave Roussy France 4/2003
Treatment Details: Patients: This multicentre Phase II study involved 52 patients with glioblastoma multiforme who had not been administered chemotherapy previously. Patients were divided into two groups – 25
 
1566 6.7 months Advanced melanoma 4 Biologic therapy
University of Chicago Cancer Research Center United States 6/2004
Treatment Details: Patients: This Phase II study involved 31 patients with advanced melanoma. Treatment: The treatment consisted of a biological therapy - the Flk-1 tyrosine kinase inhibitor SU5416. T
 
1567 6.7 months Malignant mesothelioma 5 Biologic therapy
Chemotherapy
Institut Jules Bordet Belgium 1/2011
Treatment Details: Patients: This phase 2 study involved 45 malignant mesothelioma patients who had received prior platinum-based therapy. The median age was 69 years (range of 51-80) and 73% were male. T
 
1568 6.7 months NSCLC 5 Biologic therapy
Chemotherapy
Radiation
Vanderbilt University Medical Center United States 3/2009
Treatment Details: Patients: This phase II study involved 17 patients with stage III non-small cell lung cancer. Patients had not received previous treatment. The median patient age was 58 years, and 13 of t
 
1569 6.7 months Metastatic melanoma 5 Chemotherapy
Aix-Marseille University France 7/2014
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 168 patients with a median age of 60 years; 61.
 
1570 6.7 months Relapsed/refractory peripheral T cell Lymphoma 4 Biologic therapy
Chemotherapy
Hormone
Paracelsus Medical University Salzburg Austria 1/2014
Treatment Details: Patients: This phase 2 study involved 8 relapsed/refractory peripheral T cell lymphoma patients with an average age of 63.3 years, 6 of whom were male. Treatment: Patients chemotherapy
 
Page 157 of 187  | Previous Page  | Next Page